EP1539085A2 - Composition for reinforcing apatite-based materials - Google Patents
Composition for reinforcing apatite-based materialsInfo
- Publication number
- EP1539085A2 EP1539085A2 EP03769567A EP03769567A EP1539085A2 EP 1539085 A2 EP1539085 A2 EP 1539085A2 EP 03769567 A EP03769567 A EP 03769567A EP 03769567 A EP03769567 A EP 03769567A EP 1539085 A2 EP1539085 A2 EP 1539085A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- formula
- titanium
- fluorine
- ppm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
Definitions
- composition for improving the physical-chemical characteristics of apatite-based materials has uses and process for its implementation
- the invention relates to a composition intended to improve the physico-chemical characteristics of materials based on natural or artificial apatite, in particular implants. It also relates to the use of titanium derivatives for the reinforcement of apatite-based materials, as well as to a process for the reinforcement of apatite-based materials.
- a large part of prostheses or implants for dental or medical use is made from titanium.
- titanium in the preparation of such prostheses or implants is well known. Its mechanical properties, its high resistance to corrosion and its lightness make it a material of choice for these applications.
- Titanium also shows very good compatibility with biological tissues. It generally does not alter the growth of osteoblasts, fibroblasts and gingival epithelial cells and is commonly used in the manufacture of dental or bone prostheses to replace failing tissues, including intervertebral discs and ear bones.
- the visible part of the tooth has a natural color which changes over time. This color depends in particular on the whiteness and transparency of the dental enamel, as well as the color of the underlying dentin. Enamel and dentin are generally whiter the less mineralized their main constituent, hydroxyapatite. Thus, in the absence of anomaly, the tooth is then a white-ivory color. However, different phenomena occur over time and have an influence on the color of the teeth.
- the enamel is also subject to erosion by acidic substances and by dental caries; to wear and mechanical abrasion. These factors contribute to decrease its shine.
- extrinsic stains can change the color of the tooth.
- certain foods such as coffee, tea, blueberries contain colored pigments which can attach to the surface of the teeth and alter their shade.
- Other substances such as tar contained in cigarettes or certain drug treatments can act in the same way and change the color of teeth.
- the object of the invention is to propose a new composition for reinforcing apatite-based materials, comprising compounds derived from titanium and fluorine, capable of modifying the structure of apatite.
- a first object of the invention therefore relates to such a composition.
- Another object of the invention relates to the use of titanium and fluorine derivatives for the reinforcement of apatite-based materials.
- Another object of the invention relates to a process for reinforcing apatite-based materials.
- Another object of the invention relates to a new use of compounds derived from titanium and fluorine, to protect materials based on apatite against coloring, especially extrinsic.
- apatite-based materials is understood to mean natural hydroxyapatites, in particular dental enamel, dentin, bones, as well as artificial ceramics based on calcium phosphate intended for medical applications, in particular dental implants, percutaneous or periodontal implantation devices, bone prostheses used in particular in orthopedic, maxillofacial or spinal surgery.
- composition intended to reinforce the apatite-based materials according to the invention is characterized in that it comprises at least one derivative of titanium and of fluorine corresponding to the general formula (I) below:
- composition according to the invention being further characterized in that it has, in the solubilized state, preferably in an aqueous medium, a pH less than or equal to 6.
- L ligands which can be used are in particular the benzoic acid derivatives, in particular hydroxy-2-benzoic acid of formula (IV) below and its derivatives:
- R represents a ligand of formula (II)
- R represents a ligand of formula (II)
- They can therefore exist in the form of enantiomers or diastereoisomers. These enantiomers, diastereoisomers, as well as their mixtures, including racemic mixtures, form part of the invention.
- R represents a ligand of formula (II)
- R represents a ligand of formula (II)
- Such addition salts form part of the invention.
- salts are advantageously prepared with pharmaceutically acceptable acids, but the salts of other acids which are useful, for example for the purification or the isolation of the compounds, also form part of the invention.
- R represents a ligand of formula (II)
- R represents a ligand of formula (II)
- hydrates or solvates namely in the form of associations or combinations with one or more molecules of water or with a solvent.
- Such hydrates and solvates are also part of the invention.
- a first example of a compound derived from titanium and fluorine according to the invention, obtained by using hydroxy-2-benzoic acid as ligand L, is the compound represented by formula (III) below:
- R represents a mineral compound
- K 2 TiF 6 potassium hexafluorotitanate of formula K 2 TiF 6 .
- the titanium and fluorine derivatives in which R represents a ligand L of formula (II) above can be prepared according to the method described in document WO 0105797.
- compositions of the invention have a titanium content varying from approximately 10 to approximately 1000 ppm, preferably approximately 300 ppm and a fluorine ion content varying from approximately 50 to approximately 1500 ppm, preferably approximately 240 ppm.
- compositions according to the invention further comprise an additional fluorinated compound, in particular a fluorine salt, for example sodium fluoride, sodium monofluorophosphate.
- a fluorine salt for example sodium fluoride, sodium monofluorophosphate.
- This additional fluorinated compound is present in the compositions of the invention in an amount varying from about 50 to about 1500 ppm, preferably from about 100 to about 500 ppm.
- compositions of the invention have, in the solubilized state, a pH less than or equal to 6, preferably between approximately 5 and approximately 1, depending on the mode of administration of the composition.
- the compositions of the invention are preferably dissolved in an aqueous medium, but can also be carried out, depending in particular on the titanium and fluorine derivative used, in an organic solvent such as ethanol.
- compositions of the invention allow the substitution of calcium atoms present in the apatite by titanium and the substitution of hydroxyl groups, bicarbonates or impurities present in the apatite by fluorine.
- the invention can be applied not only to dental enamel and to dentin in compositions for oral use, but also to other natural apatites, for example bone tissue, or artificial, by example of ceramics.
- compositions of the invention can be presented in various usual forms for administration in a clinical situation (topical route) or for the preparation of artificial apatites.
- compositions of the invention may be in the form, in the case of an oral application, of a toothpaste, a powder to be diluted, a spray, a gum chew, a lozenge to suck, a dental gel, an oral implant such as a patch, a mouthwash, a solution.
- a toothpaste a powder to be diluted
- a spray a gum chew
- a dental gel an oral implant such as a patch, a mouthwash
- a solution for application to the bone or to an artificial apatite
- the compositions of the invention may be in the form of a solution, a gel, a paste, a powder to be diluted.
- the forms for oral application can contain anionic, amphoteric, zwitterionic, cationic or nonionic surfactants. They may also include thickening agents, cohesion agents, sweetening, humectant or refreshing agents, preserving agents, colorants, whitening agents, flavoring or flavoring agents, essential plant oils, plasticizing agents, peptizing agents, anti-tartar agents, agents that inhibit the production of volatile sulfur compounds such as zinc salts and complexes, cicatrizers, anti-bleeding agents, polishing agents, anti-plaque agents such as chlorhexidine, hexetidine, cetylpyridinium chloride, triclosan and / or enzymes such as dextranase, mutanase, lysozymes, lactoferrin or peroxidases.
- thickening agents cohesion agents, sweetening, humectant or refreshing agents, preserving agents, colorants, whitening agents, flavoring or flavoring agents, essential plant oils, plasticizing agents,
- a first example of a composition according to the invention in the form of a powder to be diluted extemporaneously for topical administration, comprises the following elements, expressed in percentages by weight relative to the total weight of the composition:
- Composition A A:
- composition according to the invention in the form of a powder to be diluted extemporaneously for the preparation of a solution for reinforcing artificial apatites, comprises the following elements, expressed in percentages by weight relative to the total weight of the preparation:
- Composition B is a composition of Composition B:
- the pH of the composition when used to reinforce an artificial apatite, the pH of the composition, once dissolved, may be lower than in the case of topical use.
- the composition of the invention has in solution a pH less than or equal to 6, preferably between approximately 4 and approximately 1.
- Most of the compounds derived from titanium and from fluorine which can be used in the invention, for example the compound of formula (III), are acid in aqueous solution. In certain cases, it is however necessary to adjust the pH of the composition, so that it is less than or equal to 6. In other cases, it may also be necessary to increase the pH, when the composition has the solubilized state too strong an acid character.
- the pH of the composition can be adjusted, as a function of the relative acidity of the titanium and fluorine derivatives used, with additional acid or alkaline agents, as the case may be. Such agents are known in themselves for this use in compositions intended for administration to humans.
- acid agents which can be used are in particular citric acid, hydrochloric acid, lactic acid, phosphoric acid, tartaric acid and alkaline agents which can be used are in particular sodium hydroxide, monoethanolamine, diethanolamine, triethanolamine.
- compositions comprising at least one derivative of titanium and of fluorine for the reinforcement of materials based on apatite.
- the composition comprising at least one derivative of titanium and of fluorine is as defined in the above.
- the invention is particularly useful for strengthening apatite or natural or artificial hydroxyapatite as defined in the foregoing.
- the invention also relates to a process for reinforcing apatite-based materials.
- the method of the invention is characterized in that it comprises the step consisting in applying to the apatite-based material a composition comprising a derivative of "" titanium and of fluorine ⁇ as defined in the above, said composition having, in the dissolved state, a pH less than or equal to 6.
- a step of treatment with an acid or demineralizing compound can be carried out prior to the application of the composition.
- this treatment step is carried out using an acid or demineralizing agent such as citric acid, lactic acid, phosphoric acid, tartaric acid.
- the invention also relates to the use of compounds derived from titanium and fluorine, to protect materials based on apatite against colorations, especially extrinsic.
- TiFxRy (I) in which x is an integer varying from 1 to 6 and y is 0, 1 or 2, and R represents: - a compound chosen from K, Na or NH 4 , or a ligand L of formula (II) below:
- composition for buccal use defined above has, in the solubilized state, preferably in an aqueous medium, a pH less than or equal to 6.
- L ligands which can be used are in particular those described in the foregoing, in particular the compounds of formula (IV), (V), (VI), (VII), (VIII) and their derivatives.
- compositions for buccal use which can be used to protect apatite-based materials against coloring are as defined in the above, in particular as regards their content of titanium, fluorine, the excipients which can be used, their pH, their form of administration.
- the invention also relates to a process for protecting against coloring of apatite-based materials.
- the method of the invention is characterized in that it comprises the step consisting in applying to the apatite-based material a composition comprising a titanium and fluorine derivative as defined in the above, said composition having, in the solubilized state, a pH less than or equal to 6.
- Composition 1 aqueous solution of potassium hexafluorotitanate (at 200, 400 or 1000 ppm of titanium) for local application.
- Composition 2 aqueous solution of the compound of formula III (at 200, 300, 400 or 1000 ppm of titanium) for local application.
- compositions (pH between 1 and 6) are brought into contact with commercially available hydroxyapatite powder.
- Y1 and Y2 hydroxyapatite treated with composition 2 (solutions at 200 and 400 ppm of titanium, respectively)
- composition 1 to 1000 ppm of titanium Y3 composition 2 to 1000 ppm of titanium NaF: sodium fluoride with fluorine content of 1000 ppm.
- the enamel located under the treated half is examined by scanning electron microscopy. Its titanium composition was determined by elemental analysis, by means of a ray photoelectron spectroscope ⁇ X. The results show a modified hydroxyapatite which is dental enamel, due to the incorporation of titanium in the long the structure.
- composition - aqueous solution of the compound of formula III at 0.2% (corresponding to 0.036% of titanium) The solution is used in local application, at a pH around 4.6.
- a lysine precursor is used as the coloring model in the presence of a reducing sugar, which produces brown-colored melanoids by reaction.
- aqueous solution containing 100 mM of lysine and 100 mM of reducing sugar is prepared.
- the aqueous solution of the compound of formula III prepared above is mixed (50/50 v / v mixture) with the solution of lysine and reducing sugar, balanced at 60 ° C for 3 days, then diluted (1/1 v / v) either in water (solution 1) or in artificial saliva (solution 2).
- Control mixtures in which the solution of the compound of formula III is replaced by water are also prepared in the same way (solutions 3 and 4, respectively).
- the appearance of the melanoid chromophore in the mixture is measured by spectrophotometry for 15 days.
- the absorbance is measured at 500 nm. It appears that, in vitro, the solution containing the titanium and fluorine derivative inhibits the formation of colored melanoid chromophore from lysine and reducing sugar.
- Example 1 To evaluate the effects of the treatment by local application, freshly extracted human teeth are brought into contact with the same solution as in Example 1. An experimental window is defined on each tooth and the remaining zone is masked under wax. The teeth are then exposed to treatment with the same solution as in Example 1.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
- Dental Preparations (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Composition pour améliorer les caractéristiques phvsico-chimiαues de matériaux à base d'apatite. ses utilisations et procédé pour sa mise en oeuyreComposition for improving the physical-chemical characteristics of apatite-based materials. its uses and process for its implementation
L'invention se rapporte à une composition destinée à améliorer les caractéristiques physico-chimiques de matériaux à base d'apatite naturelle ou artificielle, notamment d'implants. Elle se rapporte également à l'utilisation de dérivés de titane pour le renforcement de matériaux à base d'apatite, ainsi qu'à un procédé pour le renforcement de matériaux à base d'apatite.The invention relates to a composition intended to improve the physico-chemical characteristics of materials based on natural or artificial apatite, in particular implants. It also relates to the use of titanium derivatives for the reinforcement of apatite-based materials, as well as to a process for the reinforcement of apatite-based materials.
Elle se rapporte également à l'utilisation de dérivés de titane et de fluor pour la protection contre la coloration des matériaux à base d'apatite, notamment les colorations extrinsèques, ainsi qu'à un procédé de protection contre la coloration des matériaux à base d'apatite. "~ It also relates to the use of titanium and fluorine derivatives for the protection against coloring of apatite-based materials, in particular extrinsic coloring, as well as to a method of protection against coloring of d-based materials. 'apatite. "~
Une grande partie des prothèses ou implants à usage dentaire ou médical est fabriquée à partir de titane.A large part of prostheses or implants for dental or medical use is made from titanium.
L'intérêt du titane dans la préparation de telles prothèses ou implants est bien connu. Ses propriétés mécaniques, sa grande résistance à la corrosion et sa légèreté en font un matériau de choix pour ces applications.The interest of titanium in the preparation of such prostheses or implants is well known. Its mechanical properties, its high resistance to corrosion and its lightness make it a material of choice for these applications.
Le titane montre de plus une très bonne compatibilité avec les tissus biologiques. Il n'altère généralement pas la croissance des ostéoblastes, des fibroblastes et des cellules épithéliales gingivales et est utilisé couramment dans la fabrication de prothèses dentaires ou osseuses pour remplacer les tissus défaillants, y compris les disques intervertébraux et les osselets de l'oreille.Titanium also shows very good compatibility with biological tissues. It generally does not alter the growth of osteoblasts, fibroblasts and gingival epithelial cells and is commonly used in the manufacture of dental or bone prostheses to replace failing tissues, including intervertebral discs and ear bones.
La très bonne compatibilité entre le titane et les tissus à base d'apatite s'explique en partie par la formation, à la surface du titane, d'une fine couche d'oxyde de titane capable de protéger le métal sous-jacent et de se lier aux atomes de calcium et aux groupes phosphore de l'apatite.The very good compatibility between titanium and apatite-based fabrics is partly explained by the formation, on the surface of titanium, of a thin layer of titanium oxide capable of protecting the underlying metal and of bind to calcium atoms and phosphorus groups in apatite.
Par ailleurs, la partie visible de la dent a une couleur naturelle qui évolue avec le temps. Cette couleur dépend notamment de la blancheur et de la transparence de l'émail dentaire, ainsi que de la couleur de la dentine sous-jacente. L'émail et la dentine sont généralement d'autant plus blancs que leur constituant principal, l'hydroxyapatite, est peu minéralisée. Ainsi, en l'absence d'anomalie, la dent est alors d'une couleur blanc-ivoire. Toutefois, différents phénomènes interviennent au cours du temps et ont une influence sur la couleur des dents.In addition, the visible part of the tooth has a natural color which changes over time. This color depends in particular on the whiteness and transparency of the dental enamel, as well as the color of the underlying dentin. Enamel and dentin are generally whiter the less mineralized their main constituent, hydroxyapatite. Thus, in the absence of anomaly, the tooth is then a white-ivory color. However, different phenomena occur over time and have an influence on the color of the teeth.
Ainsi, il est connu que la minéralisation de l'émail et de la dentine augmente tout au long de la vie de la dent, la rendant moins blanche et moins transparente.Thus, it is known that the mineralization of enamel and dentin increases throughout the life of the tooth, making it less white and less transparent.
L'émail est également soumis à l'érosion par des substances acides et par la carie dentaire; à l'usure et à l'abrasion mécanique. Ces facteurs contribuent à diminuer sa brillance.The enamel is also subject to erosion by acidic substances and by dental caries; to wear and mechanical abrasion. These factors contribute to decrease its shine.
Enfin, des colorations extrinsèques peuvent modifier la couleur de la dent. Par exemple, certains aliments comme le café, le thé, les myrtilles contiennent des pigments colorés qui peuvent se fixer à la surface des dents et altérer leur teinte. D'autres substances comme les goudrons contenus dans les cigarettes ou certains traitements médicamenteux peuvent agir de la même façon et modifier la couleur des dents.Finally, extrinsic stains can change the color of the tooth. For example, certain foods such as coffee, tea, blueberries contain colored pigments which can attach to the surface of the teeth and alter their shade. Other substances such as tar contained in cigarettes or certain drug treatments can act in the same way and change the color of teeth.
Le document WO 0105797 décrit des dérivés de titane ainsi que leur utilisation dans des compositions à usage buccal, en tant qu'agent de protection contre la carie dentaire. Il est décrit dans ce document que le dérivé de titane forme une couche protectrice à la surface de la dent, sous la forme d'un glacis, dans des conditions de pH variant d'environ 6,5 à environ 7,5.The document WO 0105797 describes titanium derivatives as well as their use in compositions for oral use, as a protective agent against dental caries. It is described in this document that the titanium derivative forms a protective layer on the surface of the tooth, in the form of a glaze, under pH conditions varying from approximately 6.5 to approximately 7.5.
L'invention a pour but de proposer une nouvelle composition de renfort de matériaux à base d'apatite, comprenant des composés dérivés de titane et de fluor, capable de modifier la structure de l'apatite.The object of the invention is to propose a new composition for reinforcing apatite-based materials, comprising compounds derived from titanium and fluorine, capable of modifying the structure of apatite.
Un premier objet de l'invention concerne donc une telle composition. Un autre objet de l'invention concerne l'utilisation de dérivés de titane et de fluor pour le renforcement de matériaux à base d'apatite.A first object of the invention therefore relates to such a composition. Another object of the invention relates to the use of titanium and fluorine derivatives for the reinforcement of apatite-based materials.
Un autre objet de l'invention concerne un procédé de renforcement de matériaux à base d'apatite. Un autre objet de l'invention concerne une nouvelle utilisation de composés dérivés de titane et de fluor, pour protéger les matériaux à base d'apatite contre les colorations, notamment extrinsèques.Another object of the invention relates to a process for reinforcing apatite-based materials. Another object of the invention relates to a new use of compounds derived from titanium and fluorine, to protect materials based on apatite against coloring, especially extrinsic.
Un autre objet de l'invention concerne un procédé de protection des matériaux à base d'apatite contre les colorations.Another object of the invention relates to a process for protecting apatite-based materials against coloring.
Dans le cadre de la présente invention, on entend par le terme « matériaux à base d'apatite » les hydroxyapatites naturelles, notamment l'émail dentaire, la dentine, les os, ainsi que les céramiques artificielles à base de phosphate de calcium destinées à des applications médicales, notamment implants dentaires, dispositifs d'implantation percutanés ou parodontaux, prothèses osseuses utilisées notamment en chirurgie orthopédique, maxillo-faciale ou spinale.In the context of the present invention, the term “apatite-based materials” is understood to mean natural hydroxyapatites, in particular dental enamel, dentin, bones, as well as artificial ceramics based on calcium phosphate intended for medical applications, in particular dental implants, percutaneous or periodontal implantation devices, bone prostheses used in particular in orthopedic, maxillofacial or spinal surgery.
La composition destinée à renforcer les matériaux à base d'apatite selon l'invention est caractérisée en ce qu'elle comprend au moins un dérivé de titane et de fluor répondant à la formule générale (I) ci-après :The composition intended to reinforce the apatite-based materials according to the invention is characterized in that it comprises at least one derivative of titanium and of fluorine corresponding to the general formula (I) below:
TiFxRy (I) dans laquelle x est un entier variant de 1 à 6 et y est 0, 1 ou 2, avec la condition que quand y estTiFxRy (I) in which x is an integer varying from 1 to 6 and y is 0, 1 or 2, with the condition that when y is
0, x ne représente pas 4 et R représente :0, x does not represent 4 and R represents:
- un composé choisi parmi K, Na ou NH4, ou- a compound chosen from K, Na or NH 4 , or
- un ligand L de formule (II) ci-après :- A ligand L of formula (II) below:
dans laquelle m est 0 ou 1 et n est 0, 1 ou 2; la composition selon l'invention se caractérisant de plus en ce qu'elle possède, à l'état solubilisé, de préférence en milieu aqueux, un pH inférieur ou égal à 6.wherein m is 0 or 1 and n is 0, 1 or 2; the composition according to the invention being further characterized in that it has, in the solubilized state, preferably in an aqueous medium, a pH less than or equal to 6.
Des ligands L utilisables sont notamment les dérivés d'acide benzoïque, notamment l'acide hydroxy-2-benzoïque de formule (IV) ci-après et ses dérivés : L ligands which can be used are in particular the benzoic acid derivatives, in particular hydroxy-2-benzoic acid of formula (IV) below and its derivatives:
, l'acide hydroxy-3-benzoïque de formule (V) ci-après et ses dérivés, hydroxy-3-benzoic acid of formula (V) below and its derivatives
, l'acide hydroxy-4-benzoïque de formule (VI) ci-après et ses dérivés, hydroxy-4-benzoic acid of formula (VI) below and its derivatives
, l'acide dihydroxy-2,3-benzoïque de formule (VII) ci-après et ses dérivés, 2,3-dihydroxy-benzoic acid of formula (VII) below and its derivatives
, l'acide dihydroxy-3,4-benzoïque de formule (VIII) ci-après et ses dérivés, dihydroxy-3,4-benzoic acid of formula (VIII) below and its derivatives
Les composés dans lesquels R représente un ligand de formule (II) peuvent comporter un ou plusieurs atomes de carbone asymétriques. Ils peuvent donc exister sous forme d'énantiomères ou de diastéréoisomères. Ces énantiomères, diastéréoisomères, ainsi que leurs mélanges, y compris les mélanges racémiques, font partie de l'invention. The compounds in which R represents a ligand of formula (II) may contain one or more asymmetric carbon atoms. They can therefore exist in the form of enantiomers or diastereoisomers. These enantiomers, diastereoisomers, as well as their mixtures, including racemic mixtures, form part of the invention.
Les composés dans lesquels R représente un ligand de formule (II) peuvent exister à l'état de bases ou de sels d'addition à des acides. De tels sels d'addition font partie de l'invention.The compounds in which R represents a ligand of formula (II) may exist in the form of bases or of addition salts with acids. Such addition salts form part of the invention.
Ces sels sont avantageusement préparés avec des acides pharmaceutiquement acceptables, mais les sels d'autres acides utiles, par exemple pour la purification ou l'isolement des composés, font également partie de l'invention.These salts are advantageously prepared with pharmaceutically acceptable acids, but the salts of other acids which are useful, for example for the purification or the isolation of the compounds, also form part of the invention.
Les composés dans lesquels R représente un ligand de formule (II) peuvent également exister sous forme d'hydrates ou de solvats, à savoir sous forme d'associations ou de combinaisons avec une ou plusieurs molécules d'eau ou avec un solvant. De tels hydrates et solvats font également partie de l'invention.The compounds in which R represents a ligand of formula (II) may also exist in the form of hydrates or of solvates, namely in the form of associations or combinations with one or more molecules of water or with a solvent. Such hydrates and solvates are also part of the invention.
Un premier exemple de composé dérivé de titane et de fluor selon l'invention, obtenu en utilisant comme ligand L de l'acide hydroxy-2-benzoïque, est le composé représenté par la formule (III) ci-après :A first example of a compound derived from titanium and fluorine according to the invention, obtained by using hydroxy-2-benzoic acid as ligand L, is the compound represented by formula (III) below:
Un autre exemple de dérivé de titane et de fluor selon l'invention dans lequel R représente un composé minéral est l'hexafluorotitanate de potassium de formule K2TiF6.Another example of a titanium and fluorine derivative according to the invention in which R represents a mineral compound is potassium hexafluorotitanate of formula K 2 TiF 6 .
D'autres exemples de composés utilisables dans le cadre de l'invention sont l'hexafluorotitanate de sodium de formule Na2TiF6 et l'hexafluorotitanate d'ammonium de formule (NH4)2TiF6. Les composés utilisables dans le cadre de l'invention, quand leur mode de préparation n'est pas décrit, sont disponibles dans le commerce ou décrits dans la littérature, ou bien peuvent être préparés selon des méthodes qui y sont décrites ou qui sont connues de l'Homme du métier.Other examples of compounds which can be used in the context of the invention are sodium hexafluorotitanate of formula Na 2 TiF 6 and ammonium hexafluorotitanate of formula (NH 4 ) 2 TiF 6 . The compounds which can be used in the context of the invention, when their method of preparation is not described, are commercially available or described in the literature, or else can be prepared according to methods which are described therein or which are known from the skilled person.
Les dérivés de titane et de fluor dans lesquels R représente un ligand L de formule (II) ci-dessus peuvent être préparés selon la méthode décrite dans le document WO 0105797.The titanium and fluorine derivatives in which R represents a ligand L of formula (II) above can be prepared according to the method described in document WO 0105797.
Les compositions de l'invention ont une teneur en titane variant d'environ 10 à environ 1000 ppm, de préférence d'environ 300 ppm et une teneur en ions fluor variant d'environ 50 à environ 1500 ppm, de préférence d'environ 240 ppm.The compositions of the invention have a titanium content varying from approximately 10 to approximately 1000 ppm, preferably approximately 300 ppm and a fluorine ion content varying from approximately 50 to approximately 1500 ppm, preferably approximately 240 ppm.
Selon une forme d'exécution, les compositions selon l'invention comprennent de plus un composé fluoré supplémentaire, notamment un sel de fluor, par exemple le fluorure de sodium, le monofluorophosphate de sodium.According to one embodiment, the compositions according to the invention further comprise an additional fluorinated compound, in particular a fluorine salt, for example sodium fluoride, sodium monofluorophosphate.
Ce composé fluoré supplémentaire est présent dans les compositions de l'invention en une quantité variant d'environ 50 à environ 1500 ppm, de préférence d'environ 100 à environ 500 ppm.This additional fluorinated compound is present in the compositions of the invention in an amount varying from about 50 to about 1500 ppm, preferably from about 100 to about 500 ppm.
Les compositions de l'invention possèdent, à l'état solubilisé, un pH inférieur ou égal à 6, de préférence compris entre environ 5 et environ 1 , selon le mode d'administration de la composition. La mise en solution des compositions de l'invention est réalisée de préférence en milieu aqueux, mais peut également être réalisée, en fonction notamment du dérivé de titane et de fluor utilisé, dans un solvant organique tel que l'éthanol.The compositions of the invention have, in the solubilized state, a pH less than or equal to 6, preferably between approximately 5 and approximately 1, depending on the mode of administration of the composition. The compositions of the invention are preferably dissolved in an aqueous medium, but can also be carried out, depending in particular on the titanium and fluorine derivative used, in an organic solvent such as ethanol.
On a mis en évidence qu'à de telles valeurs de pH. les compositions de l'invention permettent la substitution d'atomes de calcium présents dans l'apatite par du titane et la substitution de groupes hydroxyles, de bicarbonates ou d'impuretés présents dans l'apatite par du fluor.It has been demonstrated that at such pH values. the compositions of the invention allow the substitution of calcium atoms present in the apatite by titanium and the substitution of hydroxyl groups, bicarbonates or impurities present in the apatite by fluorine.
Cette substitution modifie la structure de l'apatite et la rend plus résistante, non seulement à l'érosion acide et à la carie dentaire, mais également à l'abrasion, à l'usure et aux chocs traumatiques. L'incorporation d'un composé fluoré supplémentaire augmente encore la résistance de l'apatite à la dissolution par les acides.This substitution modifies the structure of apatite and makes it more resistant, not only to acid erosion and tooth decay, but also to abrasion, wear and traumatic shock. The incorporation of an additional fluorinated compound further increases the resistance of apatite to dissolution by acids.
II va de soi que l'invention peut s'appliquer, non seulement à l'émail dentaire et à la dentine dans des compositions à usage buccal, mais également à d'autres apatites naturelles, par exemple le tissu osseux, ou artificielles, par exemple des céramiques.It goes without saying that the invention can be applied not only to dental enamel and to dentin in compositions for oral use, but also to other natural apatites, for example bone tissue, or artificial, by example of ceramics.
Les compositions de l'invention peuvent se présenter sous différentes formes usuelles pour l'administration en situation clinique (voie topique) ou pour la préparatiorTd'apatites artificielles.The compositions of the invention can be presented in various usual forms for administration in a clinical situation (topical route) or for the preparation of artificial apatites.
En administration par voie topique, les compositions de l'invention peuvent se présenter sous la forme, dans le cas d'une application buccale, d'un dentifrice, d'une poudre à diluer, d'un spray, d'une gomme à mâcher, d'une pastille à sucer, d'un gel dentaire, d'un implant buccal tel qu'un patch, d'un bain de bouche, d'une solution. Pour une application sur l'os ou sur une apatite artificielle, les compositions de l'invention peuvent se présenter sous la forme d'une solution, d'un gel, d'une pâte, d'une poudre à diluer.In topical administration, the compositions of the invention may be in the form, in the case of an oral application, of a toothpaste, a powder to be diluted, a spray, a gum chew, a lozenge to suck, a dental gel, an oral implant such as a patch, a mouthwash, a solution. For application to the bone or to an artificial apatite, the compositions of the invention may be in the form of a solution, a gel, a paste, a powder to be diluted.
Toutes ces formes en elles-mêmes sont bien connues de l'homme du métier. Outre les composés dérivés de titane, associés ou non à un sel de fluor, les formes mentionnées ci-dessus peuvent comprendre des excipients ou ingrédients conventionnels pour chacune de ces formes.All of these forms in themselves are well known to those skilled in the art. In addition to the compounds derived from titanium, associated or not with a fluorine salt, the forms mentioned above can comprise excipients or conventional ingredients for each of these forms.
Par exemple, les formes pour application buccale peuvent contenir des tensio-actifs anioniques, amphotères, zwittérioniques, cationiques ou non-ioniques. Elles peuvent encore comprendre des agents épaississants, des agents de cohésion, des agents édulcorants, humectants ou rafraîchissants, des agents conservateurs, des colorants, des agents blanchissants, des agents aromatisants ou de sapidité, des huiles essentielles de plante, des agents plastifiants, des agents peptisants, des agents anti-tartre, des agents inhibiteurs de la production de composés volatiles soufrés tels les sels et complexes de zinc, des cicatrisants, des agents antisaignements, des agents de polissage, des agents anti-plaque dentaire tels que la chlorhexidine, l'héxétidine, le chlorure de cétylpyridinium, le triclosan et/ou des enzymes comme la dextranase, la mutanase, les lysozymes, la lactoferrine ou les peroxydases.For example, the forms for oral application can contain anionic, amphoteric, zwitterionic, cationic or nonionic surfactants. They may also include thickening agents, cohesion agents, sweetening, humectant or refreshing agents, preserving agents, colorants, whitening agents, flavoring or flavoring agents, essential plant oils, plasticizing agents, peptizing agents, anti-tartar agents, agents that inhibit the production of volatile sulfur compounds such as zinc salts and complexes, cicatrizers, anti-bleeding agents, polishing agents, anti-plaque agents such as chlorhexidine, hexetidine, cetylpyridinium chloride, triclosan and / or enzymes such as dextranase, mutanase, lysozymes, lactoferrin or peroxidases.
Généralement, la composition selon l'invention administrée par voie topique comprend des composés dérivés de titane en une quantité telle que sa teneur en titane soit supérieure à 0,001 % en poids, de préférence comprise entre 0,01 et 0,1 % en poids, de façon plus préférée comprise entre 0,01 et 0,05 % en poids par rapport au poids total de ladite préparation.Generally, the composition according to the invention administered topically comprises compounds derived from titanium in an amount such that its titanium content is greater than 0.001% by weight, preferably between 0.01 and 0.1% by weight, more preferably between 0.01 and 0.05% by weight relative to the total weight of said preparation.
Un premier exemple de composition selon l'invention, sous la forme d'une poudre à diluer extemporanément pour administration par voie topique, comprend les éléments suivants, exprimés en pourcentages en poids par rapport au poids total de la composition :A first example of a composition according to the invention, in the form of a powder to be diluted extemporaneously for topical administration, comprises the following elements, expressed in percentages by weight relative to the total weight of the composition:
Composition A :Composition A:
- composé de formule III 9 % o- compound of formula III 9% o
- mannitol 79 %- mannitol 79%
- arôme 8 %- aroma 8%
- saccharinate de sodium 4 %- 4% sodium saccharinate
On obtient à partir d'un sachet de 500 mg de la composition ci-dessus, mis en solution dans 20 ml d'eau purifiée, une solution contenant 300 ppm de titane, de pH compris entre 3,5 et 5.A solution containing 300 ppm of titanium, with a pH between 3.5 and 5, is obtained from a 500 mg sachet of the above composition, dissolved in 20 ml of purified water.
Un autre exemple de composition selon l'invention, sous la forme d'une poudre à diluer extemporanément pour la préparation d'une solution de renforcement des apatites artificielles, comprend les éléments suivants, exprimés en pourcentages en poids par rapport au poids total de la préparation :Another example of composition according to the invention, in the form of a powder to be diluted extemporaneously for the preparation of a solution for reinforcing artificial apatites, comprises the following elements, expressed in percentages by weight relative to the total weight of the preparation:
Composition B :Composition B:
- composé de formule III 100 % On obtient à partir d'un sachet de 750 mg de la composition ci-dessus, mis en solution dans 100 ml d'eau purifiée, une solution de pH 3 environ et contenant 1000 ppm de titane.- compound of formula III 100% A solution of pH 3 and containing 1000 ppm of titanium is obtained from a 750 mg sachet of the above composition, dissolved in 100 ml of purified water.
Lorsque la composition de l'invention est administrée par voie topique, le pH de la composition à l'état solubilisé est inférieur ou égal à 6, de préférence compris entre environ 5 et environ 2.When the composition of the invention is administered topically, the pH of the composition in the dissolved state is less than or equal to 6, preferably between approximately 5 and approximately 2.
Lorsque la composition de l'invention est utilisée pour renforcer une apatite artificielle, le pH de la composition, une fois mise en solution, peut être plus bas que dans le cas d'une utilisation par voie topique. Ainsi, la composition de l'invention a en solution un pH inférieur ou égal à 6, de préférence compris entre environ 4 et environ 1.When the composition of the invention is used to reinforce an artificial apatite, the pH of the composition, once dissolved, may be lower than in the case of topical use. Thus, the composition of the invention has in solution a pH less than or equal to 6, preferably between approximately 4 and approximately 1.
La plupart des composés dérivés de titane et de fluor utilisables dans l'invention, par exemple le composé de formule (III), sont acides en solution aqueuse. Dans certains cas, il est cependant nécessaire d'ajuster le pH de la composition, pour qu'il soit inférieur ou égal à 6. Dans d'autres cas, il peut être également nécessaire d'augmenter le pH, lorsque la composition présente à l'état solubilisé un caractère acide trop fort.Most of the compounds derived from titanium and from fluorine which can be used in the invention, for example the compound of formula (III), are acid in aqueous solution. In certain cases, it is however necessary to adjust the pH of the composition, so that it is less than or equal to 6. In other cases, it may also be necessary to increase the pH, when the composition has the solubilized state too strong an acid character.
Le pH de la composition peut être ajusté, en fonction de l'acidité relative des dérivés de titane et de fluor utilisés, par des agents acides ou alcalins supplémentaires, selon le cas. De tels agents sont connus en eux-mêmes pour cette utilisation dans des compositions destinées à être administrées à l'homme.The pH of the composition can be adjusted, as a function of the relative acidity of the titanium and fluorine derivatives used, with additional acid or alkaline agents, as the case may be. Such agents are known in themselves for this use in compositions intended for administration to humans.
Par exemple, des agents acides utilisables sont notamment l'acide citrique, l'acide chlorhydrique, l'acide lactique, l'acide phosphorique, l'acide tartrique et des agents alcalins utilisables sont notamment l'hydroxyde de sodium, la monoéthanolamine, la diéthanolamine, la triéthanolamine.For example, acid agents which can be used are in particular citric acid, hydrochloric acid, lactic acid, phosphoric acid, tartaric acid and alkaline agents which can be used are in particular sodium hydroxide, monoethanolamine, diethanolamine, triethanolamine.
L'invention a également pour objet l'utilisation d'une composition comprenant au moins un dérivé de titane et de fluor pour le renforcement de matériaux à base d'apatite. Selon l'invention, la composition comprenant au moins un dérivé de titane et de fluor est telle que définie dans ce qui précède.Another subject of the invention is the use of a composition comprising at least one derivative of titanium and of fluorine for the reinforcement of materials based on apatite. According to the invention, the composition comprising at least one derivative of titanium and of fluorine is as defined in the above.
L'invention est particulièrement utile pour le renforcement d'apatite ou d'hydroxyapatite naturelle ou artificielle telle que définie dans ce qui précède.The invention is particularly useful for strengthening apatite or natural or artificial hydroxyapatite as defined in the foregoing.
L'invention a également pour objet un procédé de renforcement de matériaux à base d'apatite.The invention also relates to a process for reinforcing apatite-based materials.
Le procédé de l'invention se caractérise en ce qu'il comprend l'étape consistant à appliquer sur le matériau à base d'apatite une composition comprenant un dérivé de " "titane et de fluor têllë^que définie dans ce qui précède, ladite composition possédant, à l'état solubilisé, un pH inférieur ou égal à 6.The method of the invention is characterized in that it comprises the step consisting in applying to the apatite-based material a composition comprising a derivative of "" titanium and of fluorine ^ as defined in the above, said composition having, in the dissolved state, a pH less than or equal to 6.
Selon le procédé de l'invention, préalablement à l'application de la composition, une étape de traitement avec un composé acide ou déminéralisant peut être réalisée. De préférence, cette étape de traitement est réalisée en utilisant un agent acide ou déminéralisant tel que l'acide citrique, l'acide lactique, l'acide phosphorique, l'acide tartrique.According to the method of the invention, prior to the application of the composition, a step of treatment with an acid or demineralizing compound can be carried out. Preferably, this treatment step is carried out using an acid or demineralizing agent such as citric acid, lactic acid, phosphoric acid, tartaric acid.
Selon une variante d'exécution du procédé de l'invention, la composition appliquée sur le matériau à base d'apatite à renforcer comprend un dérivé de titane et de fluor tel que défini dans ce qui précède, et comprend de plus un composé fluoré supplémentaire, notamment sous forme de sel, tel que défini dans ce qui précède.According to an alternative embodiment of the process of the invention, the composition applied to the apatite-based material to be reinforced comprises a derivative of titanium and of fluorine as defined in the above, and further comprises an additional fluorinated compound , especially in the form of salt, as defined in the above.
L'invention a également pour objet l'utilisation de composés dérivés de titane et de fluor, pour protéger les matériaux à base d'apatite contre les colorations, notamment extrinsèques.The invention also relates to the use of compounds derived from titanium and fluorine, to protect materials based on apatite against colorations, especially extrinsic.
L'invention consiste donc en l'utilisation d'au moins un dérivé de titane et de fluor répondant à la formule générale (I) ci-après :The invention therefore consists in the use of at least one titanium and fluorine derivative corresponding to the general formula (I) below:
TiFxRy (I) dans laquelle x est un entier variant de 1 à 6 et y est 0, 1 ou 2, et R représente : - un composé choisi parmi K, Na ou NH4, ou un ligand L de formule (II) ci-après :TiFxRy (I) in which x is an integer varying from 1 to 6 and y is 0, 1 or 2, and R represents: - a compound chosen from K, Na or NH 4 , or a ligand L of formula (II) below:
dans laquelle m est 0 ou 1 et n est 0, 1 ou 2, à l'état de base ou de sel d'addition à un acide, ainsi qu'à l'état d'hydrate ou de solvat, en tant qu'agent anti-coloration des matériaux à base d'apatite dans une composition à usage buccal.in which m is 0 or 1 and n is 0, 1 or 2, in the form of an acid addition base or salt, as well as in the hydrate or solvate state, as anti-coloring agent for apatite-based materials in a composition for oral use.
La composition à usage buccal définie ci-dessus possède à l'état solubilisé, de préférence en milieu aqueux, un pH inférieur ou égal à 6. " " The composition for buccal use defined above has, in the solubilized state, preferably in an aqueous medium, a pH less than or equal to 6. ""
Des ligands L utilisables sont notamment ceux décrits dans ce qui précède, notamment les composés de formule (IV), (V), (VI), (VII), (VIII) et leurs dérivés.L ligands which can be used are in particular those described in the foregoing, in particular the compounds of formula (IV), (V), (VI), (VII), (VIII) and their derivatives.
Un premier exemple de composé dérivé de titane et de fluor utilisable dans l'invention est le composé de formule (III) défini dans ce qui précède.A first example of a compound derived from titanium and fluorine which can be used in the invention is the compound of formula (III) defined in the above.
Un autre exemple de dérivé de titane et de fluor utilisable selon l'invention dans lequel R représente un composé minéral, en plus de ceux déjà décrits dans ce qui précède, est le tétrafluorure de titane de formule TiF4.Another example of a titanium and fluorine derivative which can be used according to the invention in which R represents a mineral compound, in addition to those already described in the above, is titanium tetrafluoride of formula TiF 4 .
Les compositions à usage buccal utilisables pour protéger les matériaux à base d'apatite contre les colorations sont telles que définies dans ce qui précède, notamment quant à leur teneur en titane, fluor, les excipients utilisables, leur pH, leur forme d'administration.The compositions for buccal use which can be used to protect apatite-based materials against coloring are as defined in the above, in particular as regards their content of titanium, fluorine, the excipients which can be used, their pH, their form of administration.
Un exemple de composition à usage buccal utilisable dans l'invention, sous la forme d'une poudre à diluer extemporanément pour la préparation d'une solution anticoloration des apatites, est la composition B telle que définie dans ce qui précède.An example of a composition for buccal use which can be used in the invention, in the form of a powder to be diluted extemporaneously for the preparation of an anti-coloring solution for apatites, is composition B as defined above.
L'invention a également pour objet un procédé de protection contre la coloration des matériaux à base d'apatite. Le procédé de l'invention se caractérise en ce qu'il comprend l'étape consistant à appliquer sur le matériau à base d'apatite une composition comprenant un dérivé de titane et de fluor telle que définie dans ce qui précède, ladite composition possédant, à l'état solubilisé, un pH inférieur ou égal à 6.The invention also relates to a process for protecting against coloring of apatite-based materials. The method of the invention is characterized in that it comprises the step consisting in applying to the apatite-based material a composition comprising a titanium and fluorine derivative as defined in the above, said composition having, in the solubilized state, a pH less than or equal to 6.
Selon le procédé de l'invention, préalablement à l'application de la composition, une étape de traitement avec un composé acide ou déminéralisant peut être réalisée. De préférence, cette étape de traitement est réalisée en utilisant un agent acide ou déminéralisant tel que l'acide citrique, l'acide lactique, l'acide phosphorique, l'acide tartrique.According to the method of the invention, prior to the application of the composition, a step of treatment with an acid or demineralizing compound can be carried out. Preferably, this treatment step is carried out using an acid or demineralizing agent such as citric acid, lactic acid, phosphoric acid, tartaric acid.
Selon une variante d'exécution du procédé de l'invention, la composition appliquée sur le matériau à base d'apatite comprend un dérivé de titane et de fluor tel que défini dans ce qui précède, et comprend de plus un composé fluoré supplémentaire, notamment sous forme de sel, tel que défini dans ce qui précède.According to an alternative embodiment of the method of the invention, the composition applied to the apatite-based material comprises a titanium and fluorine derivative as defined in the above, and further comprises an additional fluorinated compound, in particular in the form of salt, as defined in the above.
Les exemples qui suivent ont pour but d'illustrer l'invention.The following examples are intended to illustrate the invention.
Exemple 1Example 1
Pour étudier les effets des compositions de l'invention sur le renforcement de l'hydroxyapatite, les compositions 1 et 2 selon l'invention sont préparées :To study the effects of the compositions of the invention on the reinforcement of hydroxyapatite, compositions 1 and 2 according to the invention are prepared:
Composition 1 : solution aqueuse d'hexafluorotitanate de potassium (à 200, 400 ou 1000 ppm de titane) pour une application locale.Composition 1: aqueous solution of potassium hexafluorotitanate (at 200, 400 or 1000 ppm of titanium) for local application.
Composition 2 : solution aqueuse du composé de formule III (à 200, 300, 400 ou 1000 ppm de titane) pour une application locale.Composition 2: aqueous solution of the compound of formula III (at 200, 300, 400 or 1000 ppm of titanium) for local application.
Modification de la structure de rhydroxyapatiteModification of the structure of hydroxyapatite
Les compositions ci-dessus (de pH compris entre 1 et 6) sont mises en contact avec de la poudre d'hydroxyapatite achetée dans le commerce.The above compositions (pH between 1 and 6) are brought into contact with commercially available hydroxyapatite powder.
La composition de l'hydroxyapatite après traitement est étudiée par spectroscopie photoélectronique à rayons X. Les résultats obtenus sont indiqués dans le tableau I ci-après.The composition of hydroxyapatite after treatment is studied by photoelectron X-ray spectroscopy. The results obtained are shown in Table I below.
TableauBoard
C : hydroxyapatite témoin (traitée avec de l'eau)C: control hydroxyapatite (treated with water)
X1 et X2 : hydroxyapatite traitée avec la composition 1 (solutions à 200 et 400 ppm de titane, respectivement)X1 and X2: hydroxyapatite treated with composition 1 (solutions at 200 and 400 ppm of titanium, respectively)
Y1 et Y2 : hydroxyapatite traitée avec la composition 2 (solutions à 200 et 400 ppm de titane, respectivement)Y1 and Y2: hydroxyapatite treated with composition 2 (solutions at 200 and 400 ppm of titanium, respectively)
Ces résultats montrent que la structure de l'hydroxyapatite s'appauvrit en calcium et en oxygène au contact des compositions de l'invention, et s'enrichit en titane et en fluor, et ce d'autant plus que la solution appliquée est plus concentrée.These results show that the structure of hydroxyapatite is depleted in calcium and oxygen on contact with the compositions of the invention, and is enriched in titanium and fluorine, all the more so when the solution applied is more concentrated. .
L'analyse des échantillons d'hydroxyapatite traitée est poursuivie par spectrométrie de masse. Le pourcentage de calcium substitué par le titane et le pourcentage de groupes hydroxyles substitués par le fluor sont comparés à ceux obtenus après mise en contact de l'hydroxyapatite avec une solution de fluorure de sodium. Les résultats obtenus sont indiqués dans le tableau II ci-après.Analysis of the samples of treated hydroxyapatite is continued by mass spectrometry. The percentage of calcium substituted by titanium and the percentage of hydroxyl groups substituted by fluorine are compared with those obtained after contacting the hydroxyapatite with a solution of sodium fluoride. The results obtained are shown in Table II below.
Tableau IITable II
X3 : composition 1 à 1000 ppm de titane Y3 : composition 2 à 1000 ppm de titane NaF : fluorure de sodium à teneur en fluor de 1000 ppm.X3: composition 1 to 1000 ppm of titanium Y3: composition 2 to 1000 ppm of titanium NaF: sodium fluoride with fluorine content of 1000 ppm.
Ces résultats montrent la substitution simultanée de calcium par du titane et de groupes hydroxyles par du fluor avec les solutions testées. Modification de la composition de l'émail dentaire après application topique Pour évaluer les effets du traitement par application locale, des dents humaines fraîchement extraites sont mises en contact avec la composition 2. Sur chaque dent une fenêtre expérimentale est définie et séparée en deux parties. Une attaque acide modérée (acide phosphorique dilué pendant 1 minute) est réalisée sur la fenêtre. L'une des moitiés de la fenêtre est ensuite isolée sous de la cire, pendant que l'autre moitié est exposée au traitement avec la composition 3 à 300 ppm de titane.These results show the simultaneous substitution of calcium by titanium and hydroxyl groups by fluorine with the solutions tested. Modification of the composition of the dental enamel after topical application To evaluate the effects of the treatment by local application, freshly extracted human teeth are brought into contact with composition 2. On each tooth an experimental window is defined and separated into two parts. A moderate acid attack (phosphoric acid diluted for 1 minute) is carried out on the window. One of the halves of the window is then insulated under wax, while the other half is exposed to treatment with composition 3 at 300 ppm of titanium.
L'émail situé sous la moitié traitée est examiné par microscopie électronique à balayage. Sa composition en titane est déterminée par analyse élémentaire, au moyen d'un spectroscope photôélectronique à rayons~X. Les résultats mettent en évidence une modification de l'hydroxyapatite qui constitue l'émail dentaire, liée à l'incorporation en profondeur de titane dans la structure.The enamel located under the treated half is examined by scanning electron microscopy. Its titanium composition was determined by elemental analysis, by means of a ray photoelectron spectroscope ~ X. The results show a modified hydroxyapatite which is dental enamel, due to the incorporation of titanium in the long the structure.
Les résultats montrent que l'invention permet non seulement la substitution des groupes hydroxyles par le fluor, mais également la substitution de calcium par du titane dans les conditions d'application locale de la composition de l'invention, en milieu acide.The results show that the invention allows not only the substitution of the hydroxyl groups by fluorine, but also the substitution of calcium by titanium under the conditions of local application of the composition of the invention, in an acid medium.
Exemple 2Example 2
Pour étudier les effets de composés dérivés de titane et de fluor sur les colorations extrinsèques des dents, on a préparé la composition suivante: - solution aqueuse du composé de formule III à 0,2 % (correspondant à 0,036% de titane) La solution est utilisée en application locale, à un pH environ 4,6.To study the effects of compounds derived from titanium and fluorine on the extrinsic colorations of the teeth, the following composition was prepared: - aqueous solution of the compound of formula III at 0.2% (corresponding to 0.036% of titanium) The solution is used in local application, at a pH around 4.6.
Effet in vitro sur les précurseurs de la coloration On utilise, comme modèle de coloration un précurseur à base de lysine en présence d'un sucre réducteur, qui produit par réaction des mélanoïdes de couleur brune.In vitro effect on coloring precursors A lysine precursor is used as the coloring model in the presence of a reducing sugar, which produces brown-colored melanoids by reaction.
Une solution aqueuse contenant 100 mM de lysine et 100 mM de sucre réducteur est préparée. La solution aqueuse du composé de formule III préparée ci-dessus est mélangée (mélange 50/50 v/v) avec la solution de lysine et de sucre réducteur, équilibrée à 60°C pendant 3 jours, puis diluée (1/1 v/v) soit dans l'eau (solution 1 ), soit dans de la salive artificielle (solution 2). Des mélanges témoins dans lesquels la solution du composé de formule III est remplacée par de l'eau sont également préparés de la même façon (solutions 3 et 4, respectivement). L'apparition du chromophore melanoïde dans le mélange est mesurée par spectrophotométrie pendant 15 jours.An aqueous solution containing 100 mM of lysine and 100 mM of reducing sugar is prepared. The aqueous solution of the compound of formula III prepared above is mixed (50/50 v / v mixture) with the solution of lysine and reducing sugar, balanced at 60 ° C for 3 days, then diluted (1/1 v / v) either in water (solution 1) or in artificial saliva (solution 2). Control mixtures in which the solution of the compound of formula III is replaced by water are also prepared in the same way (solutions 3 and 4, respectively). The appearance of the melanoid chromophore in the mixture is measured by spectrophotometry for 15 days.
Les résultats obtenus sont indiqués sur la figure 1.The results obtained are shown in Figure 1.
L'absorbance est mesurée à 500 nm. Il apparaît que, in vitro, la solution contenant le dérivé de titane et de fluor inhibe la formation de chromophore melanoïde coloré à partir de lysine et de sucre réducteur.The absorbance is measured at 500 nm. It appears that, in vitro, the solution containing the titanium and fluorine derivative inhibits the formation of colored melanoid chromophore from lysine and reducing sugar.
Des résultats analogues sont obtenus lorsque l'on utilise du fer ou de l'étain'en présence d'une source d'ion sulfures en tant que précurseurs de coloration.Similar results are obtained when using iron or tin in the presence of a source of sulphide ion as dye precursors.
Exemple 3Example 3
Protection de la dent ex vivo contre la colorationProtection of the tooth ex vivo against staining
Pour évaluer les effets du traitement par application locale, des dents humaines fraîchement extraites sont mises en contact avec la même solution que dans l'exemple 1. Une fenêtre expérimentale est définie sur chaque dent et la zone restante est masquée sous de la cire. Les dents sont ensuite exposées au traitement avec la même solution que dans l'exemple 1.To evaluate the effects of the treatment by local application, freshly extracted human teeth are brought into contact with the same solution as in Example 1. An experimental window is defined on each tooth and the remaining zone is masked under wax. The teeth are then exposed to treatment with the same solution as in Example 1.
Après rinçage, la cire est retirée et les dents sont immergées dans une solution aqueuse contenant de la lysine et un sucre réducteur, selon le modèle décrit dans l'exemple 1 , à 60°C pendant 2 jours.After rinsing, the wax is removed and the teeth are immersed in an aqueous solution containing lysine and a reducing sugar, according to the model described in Example 1, at 60 ° C for 2 days.
Les résultats montrent que les parties des dents traitées avec la solution contenant le dérivé de titane et de fluor n'ont pas subi de coloration significative, alors que les zones non traitées sont fortement colorées de brun.The results show that the parts of the teeth treated with the solution containing the titanium and fluorine derivative have not undergone significant coloring, while the untreated areas are strongly colored in brown.
La protection conférée par le dérivé de titane et de fluor dans les conditions décrites est ainsi mise en évidence directement sur la dent. The protection conferred by the titanium and fluorine derivative under the conditions described is thus demonstrated directly on the tooth.
Claims
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0211062 | 2002-09-06 | ||
| FR0211062A FR2844199B1 (en) | 2002-09-06 | 2002-09-06 | COMPOSITION FOR IMPROVING THE PHYSICOCHEMICAL CHARACTERISTICS OF APATITE MATERIALS, USE THEREOF AND METHOD FOR IMPLEMENTING THE SAME |
| FR0303472 | 2003-03-21 | ||
| FR0303472A FR2852511B1 (en) | 2003-03-21 | 2003-03-21 | USE OF TITANIUM AND FLUORINE DERIVATIVES FOR THE PROTECTION AGAINST THE COLORING OF APATITE-BASED MATERIALS, METHOD FOR THE PROTECTION AGAINST THE COLORING OF APATITE-BASED MATERIALS |
| PCT/FR2003/002643 WO2004021970A2 (en) | 2002-09-06 | 2003-09-04 | Composition for reinforcing apatite-based materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1539085A2 true EP1539085A2 (en) | 2005-06-15 |
Family
ID=31979941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03769567A Withdrawn EP1539085A2 (en) | 2002-09-06 | 2003-09-04 | Composition for reinforcing apatite-based materials |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20050287085A1 (en) |
| EP (1) | EP1539085A2 (en) |
| AR (1) | AR041149A1 (en) |
| AU (1) | AU2003278258A1 (en) |
| WO (1) | WO2004021970A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101110720B1 (en) * | 2010-04-29 | 2012-02-16 | 주식회사셀세이프 | Composition for bone-grafting or bone-filling comprising dihydroxybozoic acid derivatives |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5835486B2 (en) * | 1978-09-02 | 1983-08-03 | 株式会社ビ−ブランド・メディコ−デンタル | Composition for preventing and inhibiting caries progression |
| US4503157A (en) * | 1982-09-25 | 1985-03-05 | Ina Seito Co., Ltd. | Sintered apatite bodies and composites thereof |
| DE3301122A1 (en) * | 1983-01-14 | 1984-07-19 | Johannes-Friedrich Dr. 2000 Hamburg Osborn | CERAMIC BONE REPLACEMENT MATERIAL AND METHOD FOR THE PRODUCTION THEREOF |
| JPS61128409A (en) * | 1984-11-27 | 1986-06-16 | 株式会社村田製作所 | Dielectric ceramic composition |
| US4601899A (en) * | 1985-03-27 | 1986-07-22 | Beecham Inc. | Hydrous toothpaste containing TiF4 and chelating agent |
| US4601898A (en) * | 1985-03-27 | 1986-07-22 | Beecham Inc. | Aqueous solution containing TiF4 and chelating agent |
| DE19830795A1 (en) * | 1998-07-09 | 2000-01-13 | Klaus Heckmann | Porous ceramics |
| FR2796383B1 (en) * | 1999-07-16 | 2002-06-14 | Sanofi Synthelabo | TITANIUM DERIVATIVES, THEIR PREPARATION AND THEIR USE |
-
2003
- 2003-09-04 EP EP03769567A patent/EP1539085A2/en not_active Withdrawn
- 2003-09-04 US US10/526,581 patent/US20050287085A1/en not_active Abandoned
- 2003-09-04 AR ARP030103210A patent/AR041149A1/en not_active Application Discontinuation
- 2003-09-04 WO PCT/FR2003/002643 patent/WO2004021970A2/en not_active Ceased
- 2003-09-04 AU AU2003278258A patent/AU2003278258A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2004021970A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AR041149A1 (en) | 2005-05-04 |
| AU2003278258A1 (en) | 2004-03-29 |
| WO2004021970A3 (en) | 2004-05-06 |
| WO2004021970A2 (en) | 2004-03-18 |
| AU2003278258A8 (en) | 2004-03-29 |
| US20050287085A1 (en) | 2005-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11911495B2 (en) | Oral care compositions for promoting gum health | |
| JP7058343B2 (en) | Oral care composition to promote gingival health | |
| JP7058342B2 (en) | Oral care composition to promote gingival health | |
| CA2070084C (en) | Combined use of stannous fluoride and amine fluoride for different types of dental treatment | |
| BR112020017904B1 (en) | ORAL HYGIENE COMPOSITIONS TO PROMOTE GUM HEALTH | |
| JP2002187809A (en) | Tooth coating agent | |
| JP2001500874A (en) | Mouthwash consisting of calcium and phosphate ions in supersaturated solution | |
| KR102076611B1 (en) | Oral composition | |
| FR2604623A1 (en) | STABLE ANTIPLATE TOOTHPASTE COMPOSITION | |
| EP0428520A1 (en) | Antimicrobial composition with long-term activity. | |
| EP1539085A2 (en) | Composition for reinforcing apatite-based materials | |
| KR101293893B1 (en) | Hydrolyzed-silk-containing compositions for oral cavity | |
| CN110236973A (en) | A kind of composition improving xerostomia and its application in oral care implement | |
| FR2852511A1 (en) | Composition for strengthening apatite-based materials, e.g. teeth, bones and implants, comprises a titanium fluoride compound | |
| FR2844199A1 (en) | Composition for strengthening apatite-based materials, e.g. teeth, bones and implants, comprises a titanium fluoride compound | |
| KR102844883B1 (en) | Compositions for whitening teeth and kits comprising thereof | |
| KR20040066313A (en) | Tooth whitening composition using oriental drug | |
| AL EID | TOOTH WHITENING. A REVIEW OF ITS EFFECTS ON TOOTH BIOLOGICAL STRUCTURE. | |
| EP3644943A1 (en) | Composition comprising an antiseptic, a volatile sulfur compound neutralizer, and an anticariogenic agent | |
| US20260027028A1 (en) | Oral care compositions for promoting gum health | |
| US20260034041A1 (en) | Oral care compositions for promoting gum health | |
| CN118178232A (en) | A novel tooth grinding and polishing preparation and preparation method thereof | |
| JP2025102586A (en) | Tooth stain inhibitor | |
| US20260027029A1 (en) | Oral care compositions for promoting gum health | |
| KR20000007808A (en) | Whitening toothpaste composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20050404 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20051212 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| RTI1 | Title (correction) |
Free format text: USE OF TITANIUM AND FLUORINE COMPOUNDS FOR THE PROTECTION OF APATITE-BASED MATERIALS AGAINST COLOURATION |
|
| GRAC | Information related to communication of intention to grant a patent modified |
Free format text: ORIGINAL CODE: EPIDOSCIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20100401 |